Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pott

Showing results (991-1000 of 1,295) with videos related to

Pageof 130
Sort By:
COPD|July 13, 2022
Health-Related Quality of Life and Daily Physical Activity Level in Patients with COPD- a Cluster AnalysisMarcela Maria Carvalho da Silva, Juliano Ferreira Arcuri, Henrique Pott, et al.
Nutrients|October 28, 2023
Sex Differences in the Skeletal Muscle Response to a High Fat, High Sucrose Diet in RatsNicholas A Hulett, Leslie A Knaub, Sara E Hull, et al.
Blood|July 31, 2004
The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low-Grade Lymphoma Study GroupRoswitha Forstpointner, Martin Dreyling, Roland Repp, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|March 2, 2018
Seroprevalence of hepatitis E virus in chronic hepatitis C in BrazilGuilherme Bricks, Jorge Figueiredo Senise, Henrique Pott Junior, et al.
BMC Cancer|August 25, 2025
The MCL elderly III trial protocol: an international, randomized, open-label phase II trial to investigate the combinations of venetoclax, ibrutinib and rituximab or bendamustine, ibrutinib and rituximab in patients with treatment naive mantle cell lymphoma not eligible for dose-intensive treatmentStephanie Herold, Christian Schmidt, Carlo Visco, et al.
Neurobiology of Aging|April 16, 2025
Higher soluble ADAM10 plasma levels are associated with decreased cognitive performance in older adults carrying APOEε4Lucas Nogueira de Carvalho Pelegrini, Patricia Regina Manzine, Cecilia Patricia Popolin, et al.
Frontiers in Pharmacology|October 7, 2017
The Effects of SEA0400 on Ca<sup>2+</sup> Transient Amplitude and Proarrhythmia Depend on the Na<sup>+</sup>/Ca<sup>2+</sup> Exchanger Expression Level in Murine ModelsNils Bögeholz, Jan S Schulte, Sven Kaese, et al.
Plos Genetics|November 1, 2021
Histone deacetylase 1 controls cardiomyocyte proliferation during embryonic heart development and cardiac regeneration in zebrafishAnja Bühler, Bernd M Gahr, Deung-Dae Park, et al.
Leukemia|October 28, 2025
ctDNA dynamics demonstrates rapid treatment response to tafasitamab + R-CHOP +/- lenalidomide and predicts outcome in diffuse large B-cell lymphoma: results from the phase 1b First-MIND studyMouhamad Khouja, Britta Kehden, Derek Blair, et al.
Biochemical Pharmacology|May 20, 2024
Cardiomyocyte-specific RXFP1 overexpression protects against pressure overload-induced cardiac dysfunction independently of relaxinJ Wingert, E Meinhardt, N Sasipong, et al.
Pageof 130

Showing results (991-1000 of 1,295) with videos related to

Sort By:
Pageof 130
COPD|July 13, 2022
Health-Related Quality of Life and Daily Physical Activity Level in Patients with COPD- a Cluster AnalysisMarcela Maria Carvalho da Silva, Juliano Ferreira Arcuri, Henrique Pott, et al.
Nutrients|October 28, 2023
Sex Differences in the Skeletal Muscle Response to a High Fat, High Sucrose Diet in RatsNicholas A Hulett, Leslie A Knaub, Sara E Hull, et al.
Blood|July 31, 2004
The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low-Grade Lymphoma Study GroupRoswitha Forstpointner, Martin Dreyling, Roland Repp, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|March 2, 2018
Seroprevalence of hepatitis E virus in chronic hepatitis C in BrazilGuilherme Bricks, Jorge Figueiredo Senise, Henrique Pott Junior, et al.
BMC Cancer|August 25, 2025
The MCL elderly III trial protocol: an international, randomized, open-label phase II trial to investigate the combinations of venetoclax, ibrutinib and rituximab or bendamustine, ibrutinib and rituximab in patients with treatment naive mantle cell lymphoma not eligible for dose-intensive treatmentStephanie Herold, Christian Schmidt, Carlo Visco, et al.
Neurobiology of Aging|April 16, 2025
Higher soluble ADAM10 plasma levels are associated with decreased cognitive performance in older adults carrying APOEε4Lucas Nogueira de Carvalho Pelegrini, Patricia Regina Manzine, Cecilia Patricia Popolin, et al.
Frontiers in Pharmacology|October 7, 2017
The Effects of SEA0400 on Ca<sup>2+</sup> Transient Amplitude and Proarrhythmia Depend on the Na<sup>+</sup>/Ca<sup>2+</sup> Exchanger Expression Level in Murine ModelsNils Bögeholz, Jan S Schulte, Sven Kaese, et al.
Plos Genetics|November 1, 2021
Histone deacetylase 1 controls cardiomyocyte proliferation during embryonic heart development and cardiac regeneration in zebrafishAnja Bühler, Bernd M Gahr, Deung-Dae Park, et al.
Leukemia|October 28, 2025
ctDNA dynamics demonstrates rapid treatment response to tafasitamab + R-CHOP +/- lenalidomide and predicts outcome in diffuse large B-cell lymphoma: results from the phase 1b First-MIND studyMouhamad Khouja, Britta Kehden, Derek Blair, et al.
Biochemical Pharmacology|May 20, 2024
Cardiomyocyte-specific RXFP1 overexpression protects against pressure overload-induced cardiac dysfunction independently of relaxinJ Wingert, E Meinhardt, N Sasipong, et al.
Pageof 130